T1	PROC 1 23	Vitrectomía enzimática
T2	CHEM 13 23	enzimática
#1	AnnotatorNotes T2	C0014442; Enzymes; Amino Acid, Peptide, or Protein · Enzyme
T3	ANAT 128 137	maculares
#2	AnnotatorNotes T3	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T4	CHEM 53 61	plasmina
#3	AnnotatorNotes T4	C0016016; plasmin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T5	PROC 76 87	tratamiento
#4	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	DISO 103 137	membranas epirretinianas maculares
#5	AnnotatorNotes T6	C0339543; Epiretinal Membrane; Acquired Abnormality (?)
T7	DISO 314 317	MEM
#6	AnnotatorNotes T7	C0339543; Epiretinal Membrane; Acquired Abnormality (?)
T8	DISO 143 177	síndrome de tracción vitreomacular
#7	AnnotatorNotes T8	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T9	ANAT 164 177	vitreomacular
T10	DISO 360 364	STVM
#8	AnnotatorNotes T10	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T11	CHEM 232 240	plasmina
#9	AnnotatorNotes T11	C0016016; plasmin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T12	PROC 259 270	tratamiento
#10	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	DISO 278 312	membranas epirretinianas maculares
#11	AnnotatorNotes T13	C0339543; Epiretinal Membrane; Acquired Abnormality (?)
T14	ANAT 303 312	maculares
#12	AnnotatorNotes T14	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T15	DISO 324 358	síndrome de tracción vitreomacular
#13	AnnotatorNotes T15	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T16	ANAT 345 358	vitreomacular
T17	PROC 392 414	vitrectomía quirúrgica
T18	PROC 444 503	Estudio piloto prospectivo, de intervención, serie de casos
#14	AnnotatorNotes T18	C0150093; Case Series; Research Activity + C0031928; Pilot Projects; Research Activity + C0033522; Prospective Studies; Research Activity + C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T19	DISO 1132 1135	MEM
#15	AnnotatorNotes T19	C0339543; Epiretinal Membrane; Acquired Abnormality
T20	ANAT 1279 1292	vitreomacular
T21	DISO 545 575	membrana epirretiniana macular
#16	AnnotatorNotes T21	C0339543; Epiretinal Membrane; Acquired Abnormality (?)
T22	ANAT 568 575	macular
#17	AnnotatorNotes T22	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T23	DISO 587 621	síndrome de tracción vitreomacular
#18	AnnotatorNotes T23	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T24	ANAT 608 621	vitreomacular
T25	PROC 624 635	Tratamiento
#19	AnnotatorNotes T25	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T26	PROC 1932 1946	agudeza visual
#20	AnnotatorNotes T26	C0200150; Visual acuity testing; Diagnostic Procedure | C0846620; Measurement of visual acuity; Diagnostic Procedure
T27	CHEM 672 680	plasmina
#21	AnnotatorNotes T27	C0016016; plasmin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T28	PROC 695 711	anestesia tópica
#22	AnnotatorNotes T28	C0472473; Topical local anesthetic; Therapeutic or Preventive Procedure
T29	CHEM 716 724	plasmina
#23	AnnotatorNotes T29	C0016016; plasmin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T30	DISO 852 874	membrana epirretiniana
#24	AnnotatorNotes T30	C0339543; Epiretinal Membrane; Acquired Abnormality
T31	ANAT 881 887	retina
#25	AnnotatorNotes T31	C0035298; Retina; Body Part, Organ, or Organ Component | C1278894; Entire retina; Body Part, Organ, or Organ Component
T32	PROC 899 930	tomografía de coherencia óptica
#26	AnnotatorNotes T32	C0920367; Tomography, Optical Coherence; Diagnostic Procedure
T33	PROC 932 935	OCT
#27	AnnotatorNotes T33	C0920367; Tomography, Optical Coherence; Diagnostic Procedure
T34	PROC 942 972	mejor agudeza visual corregida
#28	AnnotatorNotes T34	C1275680; Corrected visual acuity; Diagnostic Procedure
T35	PROC 1012 1021	inyección
#29	AnnotatorNotes T35	C1533685; Injection procedure; Therapeutic or Preventive Procedure
T36	PROC 1083 1094	seguimiento
#30	AnnotatorNotes T36	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T37	DISO 1108 1130	membrana epirretiniana
#31	AnnotatorNotes T37	C0339543; Epiretinal Membrane; Acquired Abnormality
T38	PROC 2120 2133	reinyecciones
T39	ANAT 1220 1226	retina
#32	AnnotatorNotes T39	C0035298; Retina; Body Part, Organ, or Organ Component | C1278894; Entire retina; Body Part, Organ, or Organ Component
T40	DISO 1258 1292	síndrome de tracción vitreomacular
#33	AnnotatorNotes T40	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T41	DISO 1294 1298	STVM
#34	AnnotatorNotes T41	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T42	ANAT 1304 1312	membrana
#35	AnnotatorNotes T42	C0025255; Tissue membrane; Tissue | C0596901; Membrane; Cell Component
T43	ANAT 1328 1339	área foveal
T44	ANAT 1424 1430	mácula
#36	AnnotatorNotes T44	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T45	DISO 1516 1538	membrana epirretiniana
#37	AnnotatorNotes T45	C0339543; Epiretinal Membrane; Acquired Abnormality
T46	DISO 1564 1598	síndrome de tracción vitreomacular
#38	AnnotatorNotes T46	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T47	ANAT 1585 1598	vitreomacular
T48	DISO 1617 1636	efectos secundarios
#39	AnnotatorNotes T48	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T49	CHEM 1679 1687	plasmina
#40	AnnotatorNotes T49	C0016016; plasmin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T50	PROC 1702 1713	tratamiento
#41	AnnotatorNotes T50	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T51	PROC 1734 1756	vitrectomía quirúrgica
T52	PROC 1764 1778	serie de casos
#42	AnnotatorNotes T52	C0150093; Case Series; Research Activity
T53	DISO 1813 1847	membranas epirretinianas maculares
#43	AnnotatorNotes T53	C0339543; Epiretinal Membrane; Acquired Abnormality (?)
T54	ANAT 1838 1847	maculares
#44	AnnotatorNotes T54	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T55	DISO 1868 1902	síndrome de tracción vitreomacular
#45	AnnotatorNotes T55	C0730274; Vitreomacular traction syndrome; Disease or Syndrome
T56	ANAT 1889 1902	vitreomacular
T57	ANAT 2002 2010	membrana
#46	AnnotatorNotes T57	C0025255; Tissue membrane; Tissue | C0596901; Membrane; Cell Component
T58	CHEM 2148 2156	plasmina
#47	AnnotatorNotes T58	C0016016; plasmin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T59	PROC 28 49	inyección intravítrea
#48	AnnotatorNotes T59	C2069457; Intravitreal injection of pharmacologic agent; Therapeutic or Preventive Procedure
T60	ANAT 113 127	epirretinianas
T61	PROC 207 228	inyección intravítrea
#49	AnnotatorNotes T61	C2069457; Intravitreal injection of pharmacologic agent; Therapeutic or Preventive Procedure
T62	ANAT 288 302	epirretinianas
T63	ANAT 554 567	epirretiniana
T64	PROC 637 658	Inyección intravítrea
#50	AnnotatorNotes T64	C2069457; Intravitreal injection of pharmacologic agent; Therapeutic or Preventive Procedure
T65	CHEM 792 802	uroquinasa
#51	AnnotatorNotes T65	C0042071; urokinase; Amino Acid, Peptide, or Protein · Enzyme · Pharmacologic Substance
T66	ANAT 861 874	epirretiniana
T67	CHEM 1025 1033	plasmina
#52	AnnotatorNotes T67	C0016016; plasmin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T68	ANAT 1117 1130	epirretiniana
T69	ANAT 1360 1379	pliegues retinianos
T70	ANAT 1434 1454	estructura anatómica
#53	AnnotatorNotes T70	C0700276; Anatomic structures; Anatomical Structure
T71	ANAT 1525 1538	epirretiniana
T72	PROC 1654 1675	inyección intravítrea
#54	AnnotatorNotes T72	C2069457; Intravitreal injection of pharmacologic agent; Therapeutic or Preventive Procedure
T73	ANAT 1823 1837	epirretinianas
T74	Route 38 49	intravítrea
#55	AnnotatorNotes T74	C1517572; Intravitreal Route of Drug Administration; Functional Concept
T76	Route 217 228	intravítrea
#56	AnnotatorNotes T76	C1517572; Intravitreal Route of Drug Administration; Functional Concept
T77	Neg_cue 367 370	sin
T78	LIVB 506 515	Pacientes
#57	AnnotatorNotes T78	C0030705; Patients; Patient or Disabled Group
T79	LIVB 523 532	pacientes
#58	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	Route 647 658	intravítrea
#59	AnnotatorNotes T80	C1517572; Intravitreal Route of Drug Administration; Functional Concept
T81	Dose 662 668	0,2 ml
T82	Route 705 711	tópica
#60	AnnotatorNotes T82	C1522168; Topical Route of Drug Administration; Functional Concept
T83	Duration 1002 1005	mes
T84	LIVB 1058 1067	pacientes
#61	AnnotatorNotes T84	C0030705; Patients; Patient or Disabled Group
T85	Duration 1098 1103	1 mes
T91	Neg_cue 1600 1602	No
T92	Route 1664 1675	intravítrea
#62	AnnotatorNotes T92	C1517572; Intravitreal Route of Drug Administration; Functional Concept
T75	PROC 1459 1473	agudeza visual
#63	AnnotatorNotes T75	C0200150; Visual acuity testing; Diagnostic Procedure | C0846620; Measurement of visual acuity; Diagnostic Procedure
A1	Assertion T17 Negated
A2	Assertion T48 Negated
R1	Negation Arg1:T91 Arg2:T48	
T86	Neg_cue 1474 1476	no
T87	CONC 1477 1488	se modificó
A3	Assertion T87 Negated
#64	AnnotatorNotes T87	C0443172; Changed status; Quantitative Concept
R2	Negation Arg1:T86 Arg2:T87	
R3	Negation Arg1:T77 Arg2:T17	
T88	Neg_cue 1178 1181	sin
T89	Neg_cue 1190 1192	ni
T90	Observation 1193 1226	separación del plano de la retina
A4	Assertion T90 Negated
R4	Negation Arg1:T89 Arg2:T90	
T93	CONC 1182 1189	cambios
A5	Assertion T93 Negated
#65	AnnotatorNotes T93	C0443172; Changed status; Quantitative Concept
R5	Negation Arg1:T88 Arg2:T93	
T94	Spec_cue 1790 1796	parece
T95	Quantifier_or_Qualifier 1797 1805	ineficaz
A6	Assertion T95 Speculated
R6	Speculation Arg1:T94 Arg2:T95	
T96	Quantifier_or_Qualifier 1851 1861	más eficaz
A7	Assertion T96 Speculated
R7	Speculation Arg1:T94 Arg2:T96	
R8	Used_for Arg1:T2 Arg2:T1	
R9	Has_Route_or_Mode Arg1:T4 Arg2:T74	
R10	Used_for Arg1:T4 Arg2:T59	
T97	Quantifier_or_Qualifier 62 70	autóloga
#66	AnnotatorNotes T97	C0439859; Autologous (qualifier value); Qualitative Concept
R11	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T97	
T98	Quantifier_or_Qualifier 88 95	inicial
#67	AnnotatorNotes T98	C0205265; Initially; Temporal Concept
R12	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T98	
R13	Location_of Arg1:T60 Arg2:T6	
R14	Location_of Arg1:T3 Arg2:T6	
R15	Location_of Arg1:T9 Arg2:T8	
R16	Has_Route_or_Mode Arg1:T11 Arg2:T76	
R17	Used_for Arg1:T11 Arg2:T61	
R18	Used_for Arg1:T4 Arg2:T5	
R19	Used_for Arg1:T11 Arg2:T12	
R20	Location_of Arg1:T62 Arg2:T13	
R21	Location_of Arg1:T14 Arg2:T13	
R22	Location_of Arg1:T14 Arg2:T7	
R23	Location_of Arg1:T62 Arg2:T7	
R24	Location_of Arg1:T16 Arg2:T15	
R25	Location_of Arg1:T16 Arg2:T10	
R26	Experiences Arg1:T79 Arg2:T21	
R27	Experiences Arg1:T79 Arg2:T23	
R28	Location_of Arg1:T24 Arg2:T23	
R29	Location_of Arg1:T22 Arg2:T21	
R30	Location_of Arg1:T63 Arg2:T21	
R31	Experiences Arg1:T78 Arg2:T21	
R32	Experiences Arg1:T78 Arg2:T23	
R33	Has_Route_or_Mode Arg1:T27 Arg2:T80	
R34	Has_Dose_or_Strength Arg1:T27 Arg2:T81	
R35	Used_for Arg1:T27 Arg2:T64	
R36	Used_for Arg1:T27 Arg2:T25	
T99	Quantifier_or_Qualifier 681 689	autóloga
#68	AnnotatorNotes T99	C0439859; Autologous (qualifier value); Qualitative Concept
R37	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T99	
R38	Has_Route_or_Mode Arg1:T28 Arg2:T82	
R39	Before Arg1:T28 Arg2:T64	
R40	Location_of Arg1:T66 Arg2:T30	
T100	CONC 826 887	Grado de separación de la membrana epirretiniana de la retina
T101	DEVI 974 988	escala Snellen
#69	AnnotatorNotes T101	C0183370; Snellen chart; Medical Device
R41	Used_for Arg1:T101 Arg2:T34	
R42	After Arg1:T34 Arg2:T83	
R43	Before Arg1:T34 Arg2:T35	
R45	Used_for Arg1:T67 Arg2:T35	
R46	After Arg1:T32 Arg2:T83	
R47	After Arg1:T33 Arg2:T83	
R48	Before Arg1:T32 Arg2:T35	
R49	Before Arg1:T33 Arg2:T35	
R50	Has_Duration_or_Interval Arg1:T36 Arg2:T85	
T102	Observation 1068 1094	completaron el seguimiento
R52	Location_of Arg1:T68 Arg2:T37	
R53	Location_of Arg1:T68 Arg2:T19	
R54	Location_of Arg1:T39 Arg2:T90	
T103	Observation 1168 1176	adherida
R55	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T103	
R56	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T103	
R57	Location_of Arg1:T20 Arg2:T40	
R58	Location_of Arg1:T20 Arg2:T41	
R59	Location_of Arg1:T71 Arg2:T45	
R60	Location_of Arg1:T47 Arg2:T46	
T104	Observation 1459 1473;1541 1547	agudeza visual mejoró
R61	Before Arg1:T46 Arg2:T104	
R62	Used_for Arg1:T49 Arg2:T72	
R63	Has_Route_or_Mode Arg1:T49 Arg2:T92	
T105	Quantifier_or_Qualifier 1688 1696	autóloga
#71	AnnotatorNotes T105	C0439859; Autologous (qualifier value); Qualitative Concept
R64	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T105	
T106	Quantifier_or_Qualifier 1714 1721	inicial
#72	AnnotatorNotes T106	C0205265; Initially; Temporal Concept
R65	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T106	
R66	Before Arg1:T50 Arg2:T51	
R67	Before Arg1:T72 Arg2:T51	
R68	Location_of Arg1:T73 Arg2:T53	
R69	Location_of Arg1:T54 Arg2:T53	
R70	Location_of Arg1:T56 Arg2:T55	
R71	Has_Quantifier_or_Qualifier Arg1:T72 Arg2:T95	
R72	Has_Quantifier_or_Qualifier Arg1:T72 Arg2:T96	
R73	Used_for Arg1:T49 Arg2:T50	
T107	Observation 1904 1913;1929 1946	mejorando la agudeza visual
R74	Before Arg1:T72 Arg2:T107	
R75	Used_for Arg1:T58 Arg2:T38	
R76	Location_of Arg1:T31 Arg2:T30	
T108	Observation 1304 1323	membrana se despegó
R77	Location_of Arg1:T42 Arg2:T108	
T109	Observation 1408 1430	normalizando la mácula
R78	Overlap Arg1:T40 Arg2:T108	
R79	Overlap Arg1:T41 Arg2:T108	
R80	Overlap Arg1:T41 Arg2:T109	
R81	Overlap Arg1:T40 Arg2:T109	
R82	Location_of Arg1:T44 Arg2:T109	
T110	Observation 1965 1978;1996 2010	despegamiento de la membrana
R83	Location_of Arg1:T57 Arg2:T110	
R84	Causes Arg1:T72 Arg2:T110	
R86	Before Arg1:T59 Arg2:T1	
T111	Spec_cue 201 203	si
T112	Quantifier_or_Qualifier 244 270	efectiva en el tratamiento
A8	Assertion T112 Speculated
#75	AnnotatorNotes T112	C1704419; Effective; Qualitative Concept (?)
R87	Speculation Arg1:T111 Arg2:T112	
R88	Has_Quantifier_or_Qualifier Arg1:T61 Arg2:T112	
#76	AnnotatorNotes T17	C0563537; Mechanical vitrectomy by pars plana approach; Therapeutic or Preventive Procedure (?)
#77	AnnotatorNotes T102	C5554829; Follow-Up Completed; Finding
#78	AnnotatorNotes T51	C0563537; Mechanical vitrectomy by pars plana approach; Therapeutic or Preventive Procedure (?)
#79	AnnotatorNotes T95	C3242229; ineffective; Idea or Concept
#70	AnnotatorNotes T38	C0444600; Reinjection; Health Care Activity 
A9	Experiencer T78 Patient
A10	Experiencer T79 Patient
A11	Experiencer T84 Patient
R44	Has_Result_or_Value Arg1:T26 Arg2:T107	
R51	Has_Result_or_Value Arg1:T75 Arg2:T104	
